Abstract:The onset of obesity-linked type 2 diabetes (T2D) is marked by an eventual failure in pancreatic β-cell function and mass that is no longer able to compensate for the inherent insulin resistance and increased metabolic load intrinsic to obesity. However, in a commonly used model of T2D, the db/db mouse, β-cells have an inbuilt adaptive flexibility enabling them to effectively adjust insulin production rates relative to the metabolic demand. Pancreatic β-cells from these animals have markedly reduced intracellular insulin stores, yet high rates of (pro)insulin secretion, together with a substantial increase in proinsulin biosynthesis highlighted by expanded rough endoplasmic reticulum and Golgi apparatus. However, when the metabolic overload and/or hyperglycemia is normalized, β-cells from db/db mice quickly restore their insulin stores and normalize secretory function. This demonstrates the β-cell's adaptive flexibility and indicates that therapeutic approaches applied to encourage β-cell rest are capable of restoring endogenous β-cell function. However, mechanisms that regulate β-cell adaptive flexibility are essentially unknown. To gain deeper mechanistic insight into the molecular events underlying β-cell adaptive flexibility in db/db β-cells, we conducted a combined proteomic and post-translational modification specific proteomic (PTMomics) approach on islets from db/db mice and wild-type controls (WT) with or without prior exposure to normal glucose levels. We identified differential modifications of proteins involved in redox homeostasis, protein refolding, K48-linked deubiquitination, mRNA/protein export, focal adhesion, ERK1/2 signaling, and renin-angiotensin-aldosterone signaling, as well as sialyltransferase activity, associated with β-cell adaptive flexibility. These proteins are all related to proinsulin biosynthesis and processing, maturation of insulin secretory granules, and vesicular trafficking-core pathways involved in the adaptation of insulin production to meet metabolic demand. Collectively, this study outlines a novel and comprehensive global PTMome signaling map that highlights important molecular mechanisms related to the adaptive flexibility of β-cell function, providing improved insight into disease pathogenesis of T2D.

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Comments on ‘dietary Intervention Preserves Β Cell Function in Mice Through CTCF-mediated Transcriptional Reprogramming’

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

1769-P: Single-Nucleus Multiomics Reveals Unique Molecular Signatures of ß-Cell Heterogeneity and Compensation in Human Obesity

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Reversibility Ofβ-Cell-specific Transcript Factors Expression by Long-Term Caloric Restriction in Db/db Mouse

Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes

Mechanisms of Impaired Pancreatic Β‑cell Function in High‑fat Diet‑induced Obese Mice: the Role of Endoplasmic Reticulum Stress.

Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors

Proper Mtorc1 Activity is Required for Glucose Sensing and Early Adaptation in Human Pancreatic Β Cells

Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment

The Mtorc2/pkc Pathway Sustains Compensatory Insulin Secretion of Pancreatic Β Cells in Response to Metabolic Stress

Heterogeneity and altered β-cell identity in the TallyHo model of early-onset type 2 diabetes

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells

Alterations of the Ca 2+ signaling pathway in pancreatic beta-cells isolated from db/db mice

Pathological Roles of Bone Marrow Adipocyte-Derived Monocyte Chemotactic Protein-1 in Type 2 Diabetic Mice

Persistent Inflammatory Lipotoxicity Impedes Pancreatic β-cell Function in Diet-Induced Obese Mice Despite Correction of Glucotoxicity